Investigational Drug Services, UNC Hospitals — Chapel Hill, North Carolina

Investigational Drug Services, UNC Hospitals is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Drug Services, UNC Hospitals has participated in 1 clinical trials.

Therapeutic areas: Chronic Plaque Psoriasis.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Services, UNC Hospitals?

Investigational Drug Services, UNC Hospitals has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Services, UNC Hospitals conducted?

Investigational Drug Services, UNC Hospitals has 1 clinical trials on record. Their work covers Chronic Plaque Psoriasis.

Is Investigational Drug Services, UNC Hospitals accredited by Crixeo Health?

Investigational Drug Services, UNC Hospitals has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Services, UNC Hospitals?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.